We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Automatic Defibrillators Boost Cardiac Arrest Survival

By HospiMedica staff writers
Posted on 29 Jan 2002
A large US teaching hospital has reported a vast improvement in the survival of cardiac arrest patients since the installation of automatic external bedside defibrillators.

The defibrillators were installed in the cardiac care and intensive care units, step-down telemetry wards, and emergency room. More...
In the first four months of deployment, many therapy interventions were made by the devices, according to the hospital. In all cases, patients were successfully returned to normal cardiac rhythm in a matter of seconds. Because of the immediate intervention, there was no need for the crash-cart team and none of the patients required intubation. As a result, the hospital has increased the number of defibrillators available from 68 to 104.

The American Heart Association (AHA) revised its guidelines last year for cardiopulmonary resuscitation (CPR) and emergency cardiac care, placing major emphasis on the need for immediate defibrillation. The AHA stated that reducing the time to first shock by as little as one minute does more to improve patient survival than all current resuscitation interventions combined. Currently only about 20% of US patients experiencing cardiac arrest survive to discharge.

The hospital, Maimonides Medical Center (Brooklyn, New York, USA), used the Powerheart defibrillator, developed by Cardiac Science, Inc. (Irvine, CA, USA). When the Powerheart senses an abnormal heart rhythm, it automatically provides a brief electric shock through the patient's chest to the heart, restoring normal rhythm.

"The impact made at Maimonides by Powerheart technology has been dramatic and has facilitated a fundamental change in our approach to the treatment of cardiac arrest,” said Gerald Hollander, M.D., director of clinical cardiology at Maimonides. "The time from arrhythmia onset to successful defibrillation has been greatly reduced.”




Related Links:
Cardiac Science

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.